|
|
|
European Pharmaceutical Contractor
|
Advancements in science and technology – coupled with rising R&D activities – and the increasing automation of laboratories and stringency of regulatory requirements are all resulting in the generation of a large volume of scientific data from R&D, manufacturing and quality assurance processes. As a consequence, there is a growing need for life sciences firms to efficiently manage large volumes of information; enhance connectivity and productivity; comply with strict regulations; survive swelling commercial pressures; and improve quality and operational efficacy. In short, the demand for effective data management solutions such as lab informatics has increased. This is particularly pronounced in labs engaged in collecting, analysing and mining experimental information in highly automated environments.
The evolution of informatics has culminated in the development of various systems with diverse capabilities, such as:
- Lab information management systems (LIMS)
- Electronic data capture (EDC)
- Clinical data management systems (CDMS)
- Electronic lab notebooks (ELN)
- Lab execution systems (LES)
- Scientific data management systems (SDMS)
- Chromatography data systems (CDS)
- Enterprise content management (ECM)
These solutions include a number of software platforms that help automate and accelerate R&D processes; assist in tracking samples; streamline information exchange with equipment; track lab procedures; reduce turnaround time; and ensure compliance with Good Laboratory Practice standards and FDA regulations.
|
Read full article from PDF >>
|
|
 |
|
| Rate this article |
You must be a member of the site to make a vote. |
|
Average rating: |
0 |
| | | | | |
|
|
 |
News and Press Releases |
 |
When space is tight
Existing packaging lines can be retrofitted for serialization tasks,
achieving a maximum of space savings and process reliability: if
required, the system comes with an integrated checkweigher and
tamper-evident labeler.
More info >> |
|
 |
White Papers |
 |
|
Crossing the Blood Brain Barrier (BBB): Which Route to Take?
Aptar Pharma
Aptar Pharma recently hosted an expert panel/roundtable on the various approaches to treating central nervous system (CNS) diseases. This international scientific forum was held in Paris, France on December 5th, 2014. The roundtable was organized to explore and exchange views on the challenges, approaches and opportunities that exist with regard to effectively crossing the blood brain barrier (BBB) and successfully treating a host of CNS diseases.
More info >> |
|
 |
Industry Events |
 |
Vaccine Manufacturing
23-25 April 2018, RAI, Amsterdam
Changing the shape of vaccine development,
manufacturing and delivery.
More info >> |
|
|
